Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harvard Bioscience
(NQ:
HBIO
)
2.870
+0.030 (+1.05%)
Streaming Delayed Price
Updated: 10:46 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Harvard Bioscience
< Previous
1
2
Next >
HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024
August 08, 2024
HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Holley And 2 Other Stocks Under $5 Insiders Are Buying
June 17, 2024
Via
Benzinga
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
June 10, 2024
Via
Benzinga
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
May 07, 2024
HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023
March 07, 2024
HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Preview For Harvard Bioscience
November 06, 2023
Via
Benzinga
Preview: Harvard Bioscience's Earnings
August 07, 2023
Via
Benzinga
Why Harvard Bioscience Stock Rose This Week
April 27, 2023
The company reported improved revenue in Q1.
Via
The Motley Fool
Harvard Bioscience's Return On Capital Employed Overview
March 14, 2023
Via
Benzinga
Earnings Preview: Harvard Bioscience
March 08, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
A Preview Of Harvard Bioscience's Earnings
March 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 30, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter
April 17, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying
March 16, 2023
The Dow Jones closed lower by more than 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
10 Stocks Under $10 for 2023
January 03, 2023
In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10.
Via
InvestorPlace
Earnings Preview: Harvard Bioscience
November 07, 2022
Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Harvard...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 22, 2022
Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.
Via
Benzinga
$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying
August 19, 2022
U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 12, 2022
On Friday, 39 companies reached new 52-week lows.
Via
Benzinga
Looking Into Harvard Bioscience's Return On Capital Employed
May 19, 2022
Harvard Bioscience (NASDAQ:HBIO) brought in sales totaling $28.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 815.92%, resulting in a loss of $6.88...
Via
Benzinga
81 Biggest Movers From Yesterday
May 05, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
May 04, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...
Via
Benzinga
Recap: Harvard Bioscience Q1 Earnings
May 04, 2022
Harvard Bioscience (NASDAQ:HBIO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Harvard Bioscience: Q4 Earnings Insights
March 08, 2022
Harvard Bioscience (NASDAQ:HBIO) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 8, 2022
March 08, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...
Via
Benzinga
Earnings Preview: Harvard Bioscience
March 07, 2022
Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Earnings Outlook For Harvard Bioscience
March 07, 2022
Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.